Q2 FY2026 EarningsQ2 FY26 results beat consensus on revenue ($1.62B vs. $1.59B) but missed on earnings, with GAAP EPS of $0.12 vs. $0.17 mean expectation. The revenue beat was driven by a 2.5% increase in adjusted admissions and outpatient growth, despite a $57.8M YoY decline in Medicaid supplemental funding due to timing differences in New Mexico. Operating margins were pressured by rising professional fees for hospital-based providers and non-recurring restructuring/CEO transition costs ($27.2M).
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Ardent Health(ARDT) the Revenue is 1.622 B (-1.4%), Beat estimate;the EBIT is 73.61 M (-43.62%), Beat estimate;the EPS is 0.12 (-76.92%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.62B1.40%
1.59B3.38%
+0.03B1.98%
EBITExceed expectations
0.07B43.62%
0.07B45.10%
+0.00B1.48%
EPSMiss expectations
0.1276.92%
0.173866.58%
-0.053810.34%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf